5-year Follow up Study on the Comparative Performance of Two-piece Zirconia and Titanium Implants
Launched by THE UNIVERSITY OF HONG KONG · Apr 6, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two types of dental implants: a ceramic implant made of zirconia and a traditional titanium implant. The goal is to compare how well these implants perform and how safe they are over a period of five years for people who have lost a single tooth. The study will involve patients who have had a dental implant placed in a specific area of their mouth and will use modern digital technology to assess the results.
To participate in the trial, individuals must be at least 18 years old and have already received a single tooth replacement with one of the study implants. They should be willing to attend follow-up visits and allow their data to be used in the study. However, individuals who are pregnant, plan to become pregnant, or have certain health issues that might interfere with the study are not eligible. Participants can expect to receive careful monitoring and support throughout the study, helping to ensure their safety and the accuracy of the results.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- following criteria must be met for inclusion in the study:
- • Patients must have voluntarily signed the Informed Consent Form before any study related procedures are performed, are willing and able to attend scheduled follow-up visits and agree that the pseudonymized data will be collected, analyzed, and published.
- • Patients must be males or females who are a minimum of 18 years of age.
- • Patients, who have received a single tooth replacement with a study implant as per-protocol in the premolar-to-premolar area (excluding lower incisors) in the mandible and maxilla and restored with a screw retained ceramic crown.
- Exclusion Criteria:
- • Patients with conditions or circumstances, in the opinion of the Investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance or unreliability.
- • Pregnancy or intention to become pregnant at any point during the study duration.
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Düsseldorf, , Germany
Hong Kong, , Hong Kong
Patients applied
SL
CW
AG
Trial Officials
Melissa R. Fok, Dr.
Principal Investigator
The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials